Arid
DOI10.2967/jnumed.113.133348
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3’-Deoxy-3’-F-18-Fluorothymidine PET and Diffusion-Weighted MR Imaging
Schelhaas, Sonja1; Wachsmuth, Lydia2; Viel, Thomas1; Honess, Davina J.3; Heinzmann, Kathrin3; Smith, Donna-Michelle3; Hermann, Sven1; Wagner, Stefan4; Kuhlmann, Michael T.1; Mueller-Tidow, Carsten5; Kopka, Klaus4; Schober, Otmar1,4; Schaefers, Michael1,4; Schneider, Richard6; Aboagye, Eric O.7; Griffiths, John3; Faber, Cornelius2; Jacobs, Andreas H.1,8
通讯作者Jacobs, Andreas H.
来源期刊JOURNAL OF NUCLEAR MEDICINE
ISSN0161-5505
EISSN1535-5667
出版年2014
卷号55期号:6页码:983-988
英文摘要

Molecular imaging allows the noninvasive assessment of cancer progression and response to therapy. The aim of this study was to investigate molecular and cellular determinants of 3’-deoxy-3’-F-18-fluorothymidine (F-18-FLT) PET and diffusion-weighted (DIN) MR imaging in lung carcinoma xenografts. Methods: Four lung cancer cell lines (A549, HTB56, EBC1, and H1975) were subcutaneously implanted in nude mice, and growth was followed by caliper measurements. Glucose uptake and tumor proliferation were determined by F-18-FDG and F-18-FLT PET, respectively. T2-weighted MR imaging was performed, arid the apparent diffusion coefficient (ADC) was determined by DW MR imaging as an indicator of cell death. Imaging findings were correlated to histology with markers for tumor proliferation (Ki67, 5-bromo-2’-deoxyuridine [BrdU]) and cell death (caspase-3, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling). The expression of human equilibrative nucleoside transporter 1 (hENT1), thymidine kinase 1 (TK1), thymidylate synthase, and thymidine phosphorylase (TP) were analyzed by Western blot and immunohistochemistry. Thymidine levels were determined by liquid chromatography mass spectrometry. Results: Xenografts varied with respect to in vivo growth rates. MR imaging and PET revealed intratumoral heterogeneities, which were confirmed by histology. F-18-FLT uptake differed significantly between tumor lines, with A549 and H1975 demonstrating the highest radiotracer accumulation (A549, 8.5 +/- 3.2; HTB56, 4.4 +/- 0.7; EBC1, 4.4 +/- 1.2; and H1975, 12.1 +/- 3.5 maximal percentage injected dose per milliliter). In contrast, differences in F-18-FDG uptake were only marginal. No clear relationship between F-18-FLT accumulation and immunohistochemical markers for tumor proliferation (Ki67, BrdU) as well as hENT1, TK1, or TS expression was detected. However, TP was highly expressed in A549 and H1975 xenografts, which was accompanied by low tumor thymidine concentrations, suggesting that tumor thymidine levels influence F-18-FLT uptake in the tumor models investigated. MR imaging revealed higher ADC values within proliferative regions of H1975 and A549 tumors than in HTB56 and EBC1. These ADC values were negatively correlated with cell density but not directly related to cell death. Conclusion: A direct relationship of F-18-FLT with proliferation or ADC with cell death might be complicated by the interplay of multiple processes at the cellular and physiologic levels in untreated tumors. This issue must be considered when using these imaging modalities in preclinical or clinical settings.


英文关键词F-18-FLT PET DW MRI molecular imaging lung cancer
类型Article
语种英语
国家Germany ; England
收录类别SCI-E
WOS记录号WOS:000336829900022
WOS关键词POSITRON-EMISSION-TOMOGRAPHY ; TUMOR RESPONSE ; IN-VIVO ; FDG-PET ; CHEMOTHERAPY ; F-18-FLT ; PROTEIN
WOS类目Radiology, Nuclear Medicine & Medical Imaging
WOS研究方向Radiology, Nuclear Medicine & Medical Imaging
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/183593
作者单位1.Univ Munster, European Inst Mol Imaging, D-48149 Munster, Germany;
2.Univ Hosp Munster, Dept Clin Radiol, Munster, Germany;
3.Canc Res United Kingdom Cambridge Inst, Cambridge, England;
4.Univ Hosp Munster, Dept Nucl Med, Munster, Germany;
5.Univ Hosp Munster, Dept Hematol & Oncol, Munster, Germany;
6.Merck Serono, Darmstadt, Germany;
7.Univ London Imperial Coll Sci Technol & Med, Comprehens Canc Imaging Ctr, London, England;
8.Johanniter Hosp, Dept Geriatr Med, Bonn, Germany
推荐引用方式
GB/T 7714
Schelhaas, Sonja,Wachsmuth, Lydia,Viel, Thomas,等. Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3’-Deoxy-3’-F-18-Fluorothymidine PET and Diffusion-Weighted MR Imaging[J],2014,55(6):983-988.
APA Schelhaas, Sonja.,Wachsmuth, Lydia.,Viel, Thomas.,Honess, Davina J..,Heinzmann, Kathrin.,...&Jacobs, Andreas H..(2014).Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3’-Deoxy-3’-F-18-Fluorothymidine PET and Diffusion-Weighted MR Imaging.JOURNAL OF NUCLEAR MEDICINE,55(6),983-988.
MLA Schelhaas, Sonja,et al."Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3’-Deoxy-3’-F-18-Fluorothymidine PET and Diffusion-Weighted MR Imaging".JOURNAL OF NUCLEAR MEDICINE 55.6(2014):983-988.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Schelhaas, Sonja]的文章
[Wachsmuth, Lydia]的文章
[Viel, Thomas]的文章
百度学术
百度学术中相似的文章
[Schelhaas, Sonja]的文章
[Wachsmuth, Lydia]的文章
[Viel, Thomas]的文章
必应学术
必应学术中相似的文章
[Schelhaas, Sonja]的文章
[Wachsmuth, Lydia]的文章
[Viel, Thomas]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。